Novartis AG is 1.8x more valuable than ABBOTT LABORATORIES by market capitalization ($283.13 B vs $154.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABT | NVS |
|---|---|---|
| Market cap | $154.72 B | $283.13 B |
| US-listed rank | #96 | #47 |
| Revenue (latest FY) | $44.33B | - |
| Net income (latest FY) | $6.52B | - |
| Net margin | 14.7% | - |
| P/E (trailing FY) | 23.7 | - |
| SEC filings | 1,001 | 947 |
Novartis AG is 1.8x more valuable than ABBOTT LABORATORIES by market capitalization ($283.13 B vs $154.72 B).
Full pages: ABBOTT LABORATORIES and Novartis AG, or browse the full rankings.